Back to search
FDAFDA · Food and drugs·Recall number D-0889-2023

StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-102-02

Published July 5, 2023 · Recall initiated: June 5, 2023

Summary

FDA records drug Class II recall D-0889-2023, published July 5, 2023 and initiated June 5, 2023. Recalling firm: Homeocare Laboratories, Inc.; Status: Terminated; Reported quantity: 38,105/1 fl. oz. tubes; Lot: Lot #2334, exp. date Sep-23; 2363, exp. date Nov-23; 2365, exp. date Jan-24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Homeocare Laboratories, Inc.
Distributor
Product was distributed USA nationwide.
Lot
Lot #2334, exp. date Sep-23; 2363, exp. date Nov-23; 2365, exp. date Jan-24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-102-02 recalled?

Yes. FDA published recall D-0889-2023 on July 5, 2023. Reported hazard: cGMP deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter